Skip to content

Clinical trials

Withdrawn Phase 3 trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Withdrawn Country / region: Mexico Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20065
20082
20142
20153
20181
20191
20202
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asociación para Evitar la Ceguera en México8
Amzell1
Bristol-Myers Squibb1
Eli Lilly and Company1
Grupo Cooperativo de Hemopatías Malignas1
H. Lundbeck A/S1
Hospital Español de Mexico1
Hospital General de Mexico1
Inmunotek S.L.1
Janssen Infectious Diseases BVBA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 23
COVID-192
Macular Edema2
Carcinoma, Non-Small-Cell Lung1
Central Nervous System Diseases1
Diabetic Retinopathy1
Edema1
Epilepsies, Myoclonic1
Epileptic Syndromes1
Hypertension, Pulmonary1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.